CSU wins $2 million Pentagon contract to develop Ebola vaccine


“The reason why CSU was chosen as the best place to carry this out is because of the infectious disease infrastructure we have plus the investment BioMARC has made in infectious disease research,” Pierro said. “We have been inspected by the FDA and passed, so that sets us apart from other universities or facilities.”